Dadasaheb Akolkar

Employment

• Datar Cancer Genetics Director
  2013 - Present
• Thermo Fisher Scientific Inc Carlsbad FAS
  2010 - 2013

Education

• University of Tokyo Ph.D
  2006 - 2010

Projects & Funding

Projects & funding information is unavailable.

Publications (26)

• Attention U-Net-Based Segmentation and Hybrid Classification for Detection of Circulating Tumor-Associated Cells
  Cancers 2026 DOI: 10.3390/cancers18162691
  +Save
• Liquid Biopsy for Detection of Pancreaticobiliary Cancers by Functional Enrichment and Immunofluorescent Profiling of Circulating Tumor Cells and Their Clusters
  Cancers 2024 DOI: 10.3390/cancers16071400
  +Save
• Accurate prostate cancer detection based on enrichment and characterization of prostate cancer specific circulating tumor cells
  Cancer Medicine 2023 DOI: 10.1002/cam4.5649
  +Save
• Accurate Screening for Early-Stage Breast Cancer by Detection and Profiling of Circulating Tumor Cells
  Cancers 2022 DOI: 10.3390/cancers14143341
  +Save
• Accurate Prostate Cancer Detection based on Circulating Tumor Cell Profiling
  2022 DOI: 10.1101/2022.05.11.22274934
  +Save
• Accurate Screening for Early-Stage Breast Cancer by Detection and Profiling of Circulating Tumor Cells
  2022 DOI: 10.1101/2022.05.10.22274886
  +Save
• Evaluation of patient-specific cell free DNA assays for monitoring of minimal residual disease in solid tumors
  2022 DOI: 10.1101/2022.04.07.22273446
  +Save
• Circulating Tumor Cell Assay to Non-Invasively Evaluate PD-L1 and Other Therapeutic Targets in Multiple Cancers
  2022 DOI: 10.20944/preprints202201.0380.v1
  +Save
• Multi-Analyte Liquid Biopsies for Molecular Pathway Guided Personalized Treatment Selection in Advanced Refractory Cancers: A Clinical Utility Pilot Study
  2021 DOI: 10.1101/2021.12.23.21268152
  +Save
• Clinical utility of circulating tumor-associated cells to predict and monitor chemo-response in solid tumors
  Cancer Chemotherapy and Pharmacology 2021 DOI: 10.1007/s00280-020-04189-8
  +Save